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The application of endoluminal devices to treat aortic
aneurysms has become widespread, on the basis of favor-
able reports of efficacy and safety.1-3 However, depending
on the experience of the center and the endograft device
used, 50% to 75% of patients are not candidates for this
approach because of their anatomic considerations and the
limitations of currently available devices.4-8 Anatomic con-
straints include a short infrarenal neck, aneurysmal or
ectatic iliac arteries, extreme tortuosity of the aneurysm or
iliac vessels, and iliofemoral occlusive disease.
Almost 25% of patients with aortic aneurysms have
significant iliofemoral occlusive disease,9 but a smaller
number of patients have bilateral disease severe enough to
preclude device delivery through a femoral artery. Also,
heavy calcification may preclude introduction of the deliv-
ery device in the presence of luminal stenosis or even mild
tortuosity and increases the risk of vessel fracture or rup-
ture. In some patients with distal iliac occlusive disease,
successful endograft repair can still be accomplished by
means of retroperitoneal exposure and iliac reconstruc-
tion,10 creation of a sidearm common iliac graft for vascu-
lar access, or iliac artery cutdown. Unfortunately, the
benefits of a short hospital stay and quick return to func-
tion after endograft repair are mitigated under these cir-
cumstances.
In this case report, we present a patient with a thoracic
aortic aneurysm and a severe medical comorbidity that
precluded safe open repair. Infrarenal access for endograft
repair was not feasible because of severe calcific occlusive
disease involving the distal aorta and iliac arteries. In the
650
setting of compassionate device use, we chose the left
common carotid artery as the access site for endograft
repair.
CASE REPORT
The patient was a 53-year-old man with end-stage renal fail-
ure, type 1 diabetes mellitus, congestive heart failure, and severe
coronary artery disease who came to a local hospital because of
hypoglycemia. He was found to have pleural effusions by means
of a chest radiography and a saccular 4.8-cm aneurysm of the
descending aorta (Fig 1) with the configuration of a pseudo-
aneurysm was revealed by means of a chest computed tomo-
graphic study. He was transferred to our hospital for further
examination.
On admission, the patient was comfortable and afebrile. He
was pale and appeared chronically ill. His carotid pulsations were
normal without bruit, and he had a patent dialysis fistula in the
left arm. Breath sounds were diminished at the bases, and the
abdomen was benign. The femoral arteries were calcified and
pulseless, but distal perfusion was satisfactory. No tissue loss was
present. He was vigorous and led an active lifestyle that was mod-
erately restricted because of cardiopulmonary disease.
A computed tomographic study of the abdomen was per-
formed, and a circumferential calcification of the infrarenal aorta
and severe calcific occlusive disease of the common and external
iliac arteries was demonstrated. The results of surveillance blood
cultures and a tagged leukocyte scan were negative, confirming
that the aneurysm was not mycotic. Markedly reduced ventricular
function was demonstrated by means of a cardiac scan, and, in
addition, moderate to severe pulmonary hypertension was sug-
gested by means of an echocardiogram.
In this patient, the configuration and location of the
aneurysm were ideal for tube endograft treatment, but iliofemoral
access was not possible without extensive aortofemoral recon-
struction. We considered the left common carotid artery as an
alternative access site because of its large caliber, easy accessibility,
and in-line orientation with the thoracic aorta. Minimal carotid
bifurcation disease bilaterally with vessel diameters of 9 to 10 mm
was shown by means of duplex ultrasound scanning and magnetic
resonance imaging.
An extensive discussion was held with the patient. We
thought this aneurysm occurred from a localized disruption of
the aortic wall, probably from an atheromatous ulcer, and posed
a significant risk of death due to rupture in the near future. We
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Endograft treatment of aortic aneurysms has become a common procedure in many centers. However, not all patients
are candidates for this new technology, because of their vascular anatomy and device limitations. One common prob-
lem is iliofemoral occlusive disease, which when present, even in a moderate degree, may preclude introduction of the
large-diameter delivery devices currently in use. We present a case of a high-risk male patient with a thoracic aortic
aneurysm and severe occlusive disease of the iliac arteries. An alternative approach for device delivery through the
carotid artery was used and the procedure was successful with no neurologic complications. We recommend this tech-
nique for highly selected patients with an aneurysm who can undergo tube endograft repair without feasible access
through the iliac or femoral arteries. (J Vasc Surg 2001;33:650-3.)
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concluded that the patient had a prohibitive risk for open repair,
but did not have uncompensated medical disease that would
severely limit life expectancy. We offered the patient endoluminal
repair through the left carotid artery and cited a slightly increased
risk of stroke related to this approach. Approval was obtained
from the institutional review board for compassionate application
of an aortic endograft in this specific circumstance.
PROCEDURE DETAILS
The patient was prepared with a radial artery line and
pulmonary artery catheter with ventricular pacing leads. He
was placed supine on a fluoroscopy operating table in a
reversed position, with the head facing away from anesthe-
sia. The left neck and upper chest were prepared and draped.
The left common carotid artery was exposed via a low
anterior neck incision. It was soft and free of disease, and
a Rumel tourniquet was placed proximally. A 19-gauge
needle was used as a means of accessing the vessel, and a
.038-in 15J guidewire (Cook, Bloomington, Ill) was
advanced with fluoroscopic control into the thoracic
aorta. A 6F sheath (Cook) was placed, a 5F pigtail catheter
(Angiodynamics, Queensbury, NY) with 1-cm measure-
ment markers was used to perform an aortogram with 40
mL Visipaque contrast (Nycomed, Princeton, NJ; Fig 2),
and the distal and proximal graft attachment sites were
positioned with a marker board device (Guidant, Menlo
Park, Calif). A 22-mm × 10-cm Ancure tube endograft
(Guidant) was chosen for aneurysm exclusion. An oblique
arteriotomy was performed in the proximal common
carotid artery, and brisk backbleeding was observed. The
device was advanced into the artery over a 0.035-in Black
Flexfinder guidewire (Flexmedics, Minnetonka, Minn),
and hemostasis around the device was secured with a
Rumel tourniquet while the distal common carotid artery
was clamped. The distal attachment site was positioned
fluoroscopically.
We were concerned about proximal attachment site
migration once it was released from the device because we
were deploying the endograft “backward” relative to the
blood flow stream. We hypothesized that the proximal
graft could be subject to drift because of “windsock”
forces once it separated from the device before balloon
insufflation. To minimize this risk, we temporarily lowered
the systemic blood pressure and used adenosine to intro-
Fig 3. Postdeployment aortogram demonstrating exclusion of
the aneurysm.
Fig 1. Computed tomographic scan through the midthorax. There
is a 4.8-cm saccular aneurysm (arrow) of the mid-descending aorta.
Fig 2. Intraoperative aortogram before endograft deployment.
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duce temporary asystole so we could deploy the proximal
attachment site and move the balloon with a minimum of
“windsock” stress on the graft. A test dose of 24 mg of
adenosine was given by means of rapid bolus, and 7 sec-
onds of asystole was observed, with a rapid return to base-
line hemodynamics. Once the mean arterial pressure was
lowered to 50 mm Hg, the distal attachment site was
deployed, the balloon was inflated, and 48 mg of adeno-
sine was given. When asystole commenced, the balloon
was rapidly deflated and moved proximally after the release
of the proximal attachment site and was used to set the
proximal hooks. Normal cardiac function quickly
resumed, and no drift was observed. The graft was dilated
proximally to distally with a 22-mm Tyshak balloon (B.
Braun Medical, Bethlehem, Pa) at 1.5 atm. Successful
exclusion of the aneurysm was demonstrated by means of
a follow-up anteroposterior and lateral angiogram (Fig 3).
The carotid artery was repaired with interrupted sutures,
and flow was reestablished after 60 minutes of carotid
clamping.
The patient woke neurologically intact and was dis-
charged on the second postoperative day. Correct graft
placement without attachment site leakage and partial
aneurysm thrombosis was shown by means of a computed
tomographic scan of the chest on postoperative day 1.
DISCUSSION
Endoluminal repair of aortic aneurysms is particularly
appealing for functional patients who have a severe med-
ical comorbidity, particularly coronary artery disease. This
group of patients is also more likely to have diabetes mel-
litus, renal insufficiency, and peripheral vascular disease,
and consequently, these cases present greater difficulties
with endograft access through the femoral or iliac arteries.
Because of severe aortoiliac disease, our patient did
not have a suitable device access site for conventional
deployment techniques through the lower extremities. We
chose the carotid artery as an alternative because of its
large caliber, easy access, and “in-line” orientation with
the descending aorta. We also considered the right axillary
artery, but it was revealed by means of duplex ultrasound
scan to have a luminal diameter of 6 mm, which was
judged to be too small for the deployment device. The
subclavian artery was also considered, but because of the
increased risk of peripheral nerve injury and local wound
complications associated with exposure, we did not use it.
Furthermore, we think that the axillary and subclavian
approaches carry some risk of vertebral artery emboliza-
tion, particularly when the deployed device is withdrawn.
The left carotid was chosen as a matter of convenience for
right-handed surgeons.
Our main concern was the risk of stroke from cerebral
hypoperfusion or emboli. Minimal (< 20%-30%) stenosis
at the carotid bifurcation, mild thickening of the common
carotid bilaterally, and patent vertebral arteries with pro-
grade flow were demonstrated by means of duplex ultra-
sound scanning. We also measured the luminal diameter
to be 8 to 9 mm and found that suitable for insertion of a
24F catheter. The patency and size of the extracranial
carotid vessels were confirmed by means of magnetic res-
onance angiography.
We considered the risk of cerebral ischemia caused by
common carotid clamping to be low. Generally, common
carotid artery clamping is well tolerated because of collat-
eral flow through the external carotid system. Berguer et
al11 documented this in their series of 182 great vessel
reconstructions via the cervical approach. Three perioper-
ative strokes (1.6%) were attributable to intraoperative
ischemia or embolization, and the remaining five strokes
were associated with early graft occlusion. No shunts or
electroencephalographic monitoring was used in these
patients. We acknowledge that there may be a role for
cerebral monitoring in cases like ours, but given the
approach and the size of the deployment device, in-line
shunting through the carotid artery was not possible.
Consequently, we did not use electroencephalographic
monitoring, and we minimized the period of induced
hypotension to 5 minutes, because that time represented
the greatest risk of cerebral hypoperfusion injury. We were
also reassured that collateral perfusion was adequate after
observing brisk backbleeding from the distal common
carotid artery at the start of the procedure. During the
remainder of the procedure, the mean arterial pressure was
maintained at 80 to 90 mm Hg.
Systemic anticoagulation with heparin was induced
before needle access, and the distal common carotid artery
was clamped during device insertion and deployment to
minimize the risk of embolization. The repaired artery was
vigorously flushed and backbled before completing the
closure while still anticoagulated.
The Ancure endograft was deployed in a reversed
fashion from its original design relative to flowing blood.
Ordinarily, the proximal attachment site is deployed first,
and subsequent filling of the graft facilitates body and
limb expansion before distal deployment. In our case, the
distal attachment site was deployed first, so “windsock”
forces actually favor graft collapse as they exert pressure
on the outside of the fabric tube. We were concerned that
with release of the proximal attachment site there could
be graft migration from these forces before we could
move the integrated balloon up and “seat” the proximal
attachment site hooks. To minimize “windsock” force, we
lowered the mean arterial pressure to 50 mm Hg and
gave a bolus of adenosine that induced profound brady-
cardia and further hypotension that completely reversed
after 10 seconds. This time interval was sufficient to
deploy and seat the proximal stent, and no graft migra-
tion was observed.
In summary, we describe a novel approach for endo-
graft treatment of aortic aneurysms through the carotid
artery. Although it carries some increased risk of cere-
brovascular complications, the carotid approach offers a
technically straightforward access site for tube endograft
deployment in patients who would not otherwise be can-
didates for open repair or endograft placement through
the femoral or pelvic approach.
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